The FDA added it to injectable semaglutide in January 2025, and it climbs the dose axis like everything else. Burning or tingling skin tracks the dose, not the weight lost, and an active-comparator study put the risk about twice that of another weight-loss drug. The mechanism is unsettled: the tempting "it is the drugs signaling arm" story is ruled out, because the strongest GLP-1 signaler in the class carries no such signal
The positive effect of CoQ10 treatments is recognized in patients with heart failure and myocardial ischemia, such as the reduction of oxidative stress derived from cardiovascular causes, decrease in mortality and hospitalization and improvement in cardiac function [175, 176]
In the United States, iron deficiency affects around one in four adults
However, skin changes still require time
Risks, Legality, and Sourcing Concerns While BPC157 is praised for its regenerative potential, it lives in a regulatory gray area and with that comes a number of safety, sourcing, and legal considerations for consumers
